Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Swiftmerge Acquisition A | IVCP | Nov 25, 2024 | 11.25 | +0.81 |
Swiftmerge Acquisition Unit | IVCPU | Nov 25, 2024 | 11.10 | 0.00 |
Swiss Franc Trust | FXF | Nov 25, 2024 | 100.24 | +0.92 |
Swiss Helvetia Fund | SWZ | Nov 25, 2024 | 7.81 | +0.13 |
Switzerland Alphadex First Trust | FSZ | Nov 25, 2024 | 65.15 | +1.23 |
Switzerland Index MSCI Ishares | EWL | Nov 25, 2024 | 47.41 | +0.28 |
SWK Holdings | SWKH | Nov 25, 2024 | 15.95 | +0.38 |
Swvl Holdings A | SWVL | Nov 25, 2024 | 6.41 | +4.06 |
SYLA Technologies Co., Ltd. - American Depositary Shares | SYT | Nov 25, 2024 | 1.71 | +4.94 |
Sylvamo | SLVM | Nov 25, 2024 | 95.32 | +4.86 |
Symbotic | SYM | Nov 25, 2024 | 37.47 | -3.39 |
Synaptics | SYNA | Nov 25, 2024 | 81.65 | +6.73 |
Synaptogenix | SNPX | Nov 25, 2024 | 2.71 | +4.23 |
Synchronoss Technologies | SNCR | Nov 25, 2024 | 9.56 | +0.42 |
Synchrony Financial | SYF | Nov 25, 2024 | 67.04 | +1.59 |
Synchrony Financial Pref A | SYF-B | Nov 25, 2024 | 26.17 | +0.23 |
Synchrony Financial Pref A | SYF-A | Nov 25, 2024 | 20.40 | -0.87 |
Syndax Pharmaceuticals | SNDX | Nov 25, 2024 | 16.73 | +3.98 |
Synergetics Inc | FTGC | Nov 25, 2024 | 23.66 | -0.88 |
Synergy CHC | SNYR | Nov 25, 2024 | 5.89 | 0.00 |
Synlogic | SYBX | Nov 25, 2024 | 1.39 | -2.80 |
Synopsys | SNPS | Nov 25, 2024 | 561.87 | -0.57 |
Synovus Financial | SNV | Nov 25, 2024 | 58.67 | +1.82 |
Synovus Financial D Pref | SNV-D | Nov 25, 2024 | 25.50 | +0.16 |
Synovus Financial E Pref | SNV-E | Nov 25, 2024 | 26.40 | +0.06 |
Syntec Optics | OPTX | Nov 25, 2024 | 0.87 | -0.85 |
Sypris Solutions | SYPR | Nov 25, 2024 | 1.39 | +0.72 |
Syra Health | SYRA | Nov 25, 2024 | 0.37 | +2.08 |
Syros Pharmaceuticals | SYRS | Nov 25, 2024 | 0.26 | -12.28 |
Sysco | SYY | Nov 25, 2024 | 76.88 | +1.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.